Published in
American Society of Hematology, Blood, 25(127), p. 3202-3214, 2016
DOI: 10.1182/blood-2015-10-676536
Links
Tools
A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma
Journal article published in 2016 by
Aneta Schieferdecker,
Anna Oberle,
Benjamin Thiele,
Fabian Hofmann,
Markus Göthel,
Sebastian Miethe,
Michael Hust,
Friederike Braig,
Mareike Voigt,
Ute-Marie von Pein,
Friedrich Koch-Nolte 
,
Friedrich Haag,
Malik Alawi,
Daniela Indenbirken,
Adam Grundhoff
and other authors.
,
Friedrich Haag,
Malik Alawi,
Daniela Indenbirken,
Adam Grundhoff
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points The myeloma transplant B-cell immunome is predictive for response to treatment. It may be exploited by immunosequencing and library technology as a source for unique target structures and antibodies for immunotherapy.